Congress Materials – Elevate Dermatology Summer Conference 2025
2025 Elevate Dermatology Summer Conference | Jul 23-27 | Park City, UT
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23–Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-blind, Placebo-Controlled ICONIC-LEAD Trial
Robert Bissonnette, Jennifer Soung, Adelaide Hebert, Andrew E. Pink, Andreas Pinter, Yuling Shi, Megan Miller, Joseph Cafone, Jing Zhi (Gigi) Jiang, Cynthia DeKlotz, Mark G. Lebwohl
This document will be available on July 23 2025
Inhibition of structural damage progression with guselkumab, a selective IL-23i, in participants with active PsA: Results through Week 24 of the phase 3b, randomized, double-blind, placebo-controlled APEX study
Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Soumya D Chakravarty, Proton Rahman, Désirée van der Heijde
This document will be available on July 23 2025
Phase 3 Results From an Innovative Trial Design of Treating Plaque Psoriasis Involving Difficult-to-Treat, High-Impact Sites With Icotrokinra, a Targeted Oral Peptide That Selectively Inhibits the IL-23–Receptor
Melinda J. Gooderham, Edward Lain, Robert Bissonnette, Yu-Huei Huang, Charles Lynde, Matthias Hoffmann, Eingun James Song, Jessica H. Rubens, Amy M. DeLozier, Ming-Chun Hsu, Richard B. Warren
This document will be available on July 23 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.